Evidence map›Paper›PMID 39356758›Full record

ArticleScience advances2024

Substrate recognition principles for the PP2A-B55 protein phosphatase.

Thomas Kruse, Dimitriya H Garvanska, Julia K Varga, William Garland, Brennan C McEwan, Jamin B Hein, Melanie Bianca Weisser, Iker Benavides-Puy, Camilla Bachman Chan, Paula Sotelo-Parrilla and 6 more

Abstract read
In one paragraph

Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Article
  3. FAM122A inhibition of PP2A-B55 through a bipartite binding mechanism.bioRxiv : the preprint server for biology · 2026
    Article
  4. Switching of the c-Myc protein degradation pathway depending on the PP2A-B55α complex levels.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. Review
  7. Houge-Janssens syndrome.European journal of human genetics : EJHG · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Thomas KruseNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, Blegdamsvej 3B, 2200 Copenhagen, Denmark.ORCID 0000-0002-2619-7388
Dimitriya H GarvanskaNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, Blegdamsvej 3B, 2200 Copenhagen, Denmark.ORCID 0009-0002-4864-4684
Julia K VargaDepartment of Microbiology and Molecular Genetics, Institute for Biomedical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112001, Israel.ORCID 0000-0002-5318-2798
William GarlandDepartment of Molecular Biology and Genetics, Aarhus University, Universitetsbyen 81, Aarhus, Denmark.ORCID 0000-0001-5167-8004
Brennan C McEwanBiochemistry and Cell Biology, Geisel School of Medicine at Dartmouth College, Hanover, NH, USA.ORCID 0000-0002-9545-1087
Jamin B HeinNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, Blegdamsvej 3B, 2200 Copenhagen, Denmark.ORCID 0000-0002-2887-5082
Melanie Bianca WeisserNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, Blegdamsvej 3B, 2200 Copenhagen, Denmark.ORCID 0000-0003-3946-3929
Iker Benavides-PuyNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, Blegdamsvej 3B, 2200 Copenhagen, Denmark.ORCID 0009-0009-4601-847X
Camilla Bachman ChanNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, Blegdamsvej 3B, 2200 Copenhagen, Denmark.
Paula Sotelo-ParrillaGene Center Munich, Ludwig-Maximilians-Universität München, Munich 81377, Germany.ORCID 0000-0002-6333-1005
Blanca Lopez MendezNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, Blegdamsvej 3B, 2200 Copenhagen, Denmark.ORCID 0000-0001-8541-4904
A Arockia JeyaprakashGene Center Munich, Ludwig-Maximilians-Universität München, Munich 81377, Germany.ORCID 0000-0002-1889-8635
Ora Schueler-FurmanDepartment of Microbiology and Molecular Genetics, Institute for Biomedical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112001, Israel.ORCID 0000-0002-1624-0362
Torben Heick JensenDepartment of Molecular Biology and Genetics, Aarhus University, Universitetsbyen 81, Aarhus, Denmark.ORCID 0000-0001-5127-1239
Arminja N KettenbachBiochemistry and Cell Biology, Geisel School of Medicine at Dartmouth College, Hanover, NH, USA.ORCID 0000-0003-3979-4576
Jakob NilssonNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, Blegdamsvej 3B, 2200 Copenhagen, Denmark.ORCID 0000-0003-4100-1125

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
Phosphorylation Signaling by Phosphoprotein PhosphatasesR35GM119455 · NIGMS · DARTMOUTH COLLEGE · PI Arminja Nadine Kettenbach · 2016 to 2026
$5.1M
NCI NIH HHS P30 CA023108NIGMS NIH HHS R35 GM119455Wellcome Trust
6 · The paper itself

Abstract

The PP2A-B55 phosphatase regulates a plethora of signaling pathways throughout eukaryotes. How PP2A-B55 selects its substrates presents a severe knowledge gap. By integrating AlphaFold modeling with comprehensive high-resolution mutational scanning, we show that α helices in substrates bind B55 through an evolutionary conserved mechanism. Despite a large diversity in sequence and composition, these α helices share key amino acid determinants that engage discrete hydrophobic and electrostatic patches. Using deep learning protein design, we generate a specific and potent competitive peptide inhibitor of PP2A-B55 substrate interactions. With this inhibitor, we uncover that PP2A-B55 regulates the nuclear exosome targeting (NEXT) complex by binding to an α-helical recruitment module in the RNA binding protein 7 (RBM7), a component of the NEXT complex. Collectively, our findings provide a framework for the understanding and interrogation of PP2A-B55 function in health and disease.

Indexed as

Protein BindingProtein Phosphatase 2Amino Acid SequenceHumansModels, MolecularRNA-Binding ProteinsSubstrate SpecificityProtein Phosphatase 2RNA-Binding Proteins

Identifiers

PMID39356758
PMCPMC11446282

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.